Haemostatic abnormalities and clinical findings in Vipera palaestinae-envenomed dogs

Veterinary Journal

Volumn 185, Issue 2, 2010, Pages 180-187

  Aroch, I ^a   Yas Natan, E ^a   Kuzi, S ^a   Segev, G ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Antithrombin; Canine; Coagulopathy; D dimer; Disseminated intravascular coagulation; Thrombocytopenia

Indexed keywords

AMPICILLIN; ANTITHROMBIN; D DIMER; DIPHENHYDRAMINE; FIBRINOGEN; NARCOTIC ANALGESIC AGENT; RINGER LACTATE SOLUTION; SPIDER VENOM ANTISERUM; VENOM ANTISERUM; VIPER VENOM;

ANTITHROMBIN ACTIVITY; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING PARAMETERS; DISSEMINATED INTRAVASCULAR CLOTTING; DOG; ENVENOMATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOLOGY; HEMOSTASIS; HYPERCOAGULABILITY; ISRAEL; LEUKOCYTE COUNT; MALE; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; POISONOUS SNAKE; PROSPECTIVE STUDY; PROTHROMBIN TIME; SNAKEBITE; SYMPTOMATOLOGY; THROMBOCYTE COUNT; VIPERA PALAETINAE; ANIMAL; BLOOD; BLOOD ANALYSIS; CHEMICALLY INDUCED; COMPLICATION; DOG DISEASE; DRUG EFFECTS; RISK FACTOR; VETERINARY; VIPERIDAE;

ANIMALS; ANTIVENINS; BLOOD CHEMICAL ANALYSIS; DISSEMINATED INTRAVASCULAR COAGULATION; DOG DISEASES; DOGS; FEMALE; HEMOSTASIS; ISRAEL; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SNAKE BITES; VIPER VENOMS; VIPERIDAE;

ANIMALIA; CANIS FAMILIARIS; VIPERA PALAESTINAE; VIPERINAE;

EID: 77954032462     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2009.05.024     Document Type: Article

References (64)

1. Aroch I., Harrus S. Retrospective study of the epidemiological, clinical, haematological and biochemical findings in 109 dogs poisoned by Vipera xanthina palestinae. Veterinary Record 1999, 144:532-535.
2. Aroch I., Segev G., Klement E., Shipov A., Harrus S. Fatal Vipera xanthina palestinae envenomation in 16 dogs. Veterinary and Human Toxicology 2004, 46:268-272.
3. Ben Abraham R., Winkler E., Eshel G., Barzilay Z., Paret G. Snakebite poisoning in children - a call for unified clinical guidelines. European Journal of Emergency Medicine 2001, 8:189-192.
4. Bentur Y., Cahana A. Unusual local complications of Vipera palaestinae bite. Toxicon 2003, 41:633-635.
5. Bentur Y., Zveibel F., Adler M., Raikhlin B. Delayed administration of Vipera xanthina palaestinae antivenin. Journal of Clinical Toxicology 1997, 35:257-261.
6. Bentur Y., Raikhlin-Eisenkraft B., Galperin M. Evaluation of antivenom therapy in Vipera palaestinae bites. Toxicon 2004, 44:53-57.
7. Bicher H.I., Gitter S., Rosen M. On the mechanism of Vipera palestinae venom-induced shock. Bibliotheca Anatomica 1965, 7:429-433.
8. Bicher H.I., Roth M., Gitter S. Neurotoxic activity of Vipera palestinae venom. Depression of central autonomic vasoregulatory mechanisms. Medicina et Pharmacologia Experimentalis 1966, 14:349-359.
9. Boffa M.C., Boffa G.A. Correlations between the enzymatic activities and the factors active on blood coagulation and platelet aggregation from the venom of Vipera aspis. Biochimica et Biophysica Acta 1974, 354:275-290.
10. Boffa M.C., Boffa G.A. A phospholipase A2 with anticoagulant activity. II. Inhibition of the phospholipid activity in coagulation. Biochimica et Biophysica Acta 1976, 429:839-852.
11. Boffa G.A., Boffa M.C., Winchenne J.J. A phospholipase A2 with anticoagulant activity. I. Isolation from Vipera berus venom and properties. Biochimica et Biophysica Acta 1976, 429:828-838.
12. Brown R.S., Brown M.B., Bdolah A., Kochva E. Accumulation of some secretory enzymes in venom glands of Vipera palaestinae. American Journal of Physiology 1975, 229:1675-1679.
13. Bruchim Y., Klement E., Saragusty J., Finkeilstein E., Kass P., Aroch I. Heat stroke in dogs: a retrospective study of 54 cases (1999-2004) and analysis of risk factors for death. Journal of Veterinary Internal Medicine 2006, 20:38-46.
14. Coppola M., Hogan D.E. Venomous snakes of southwest Asia. The American Journal of Emergency Medicine 1992, 10:230-236.
15. Efrati P. Clinical manifestations and treatment of viper bite in Israel. Toxicon 1969, 7:29-31.
16. Efrati P., Reif L. Clinical and pathological observations of sixty-five cases of viper bite in Israel. The American Journal of Tropical Medicine and Hygiene 1953, 2:1085-1108.
17. Grotto L., Moroz C., De Vries A., Goldblum N. Isolation of Vipera palestinae hemorrhagin and distinction between its hemorrhagic and proteolytic activities. Biochimica et Biophysica Acta 1967, 133:356-362.
18. Grotto L., Jerushalmy Z., De Vries A. Effect of purified Vipera palestinae hemorrhagin on blood coagulation and platelet function. Thrombosis et Diathesis Haemorrhagica 1969, 22:482-495.
19. Hackett T.B., Wingfield W.E., Mazzaferro E.M., Benedetti J.S. Clinical findings associated with prairie rattlesnake bites in dogs: 100 cases (1989-1998). Journal of the American Veterinary Medical Association 2002, 220:1675-1680.
20. Kamiguti A.S. Platelets as targets of snake venom metalloproteinases. Toxicon 2005, 45:1041-1049.
21. Kamiguti A.S., Rugman F.P., Theakston R.D., Franca F.O., Ishii H., Hay C.R. The role of venom haemorrhagin in spontaneous bleeding in Bothrops jararaca envenoming. Butantan Institute antivenom study group. Thrombosis and Haemostasis 1992, 67:484-488.
22. Kangström L.E. Snake bites (Vipera berus) in dogs and cats. Svensk Veterinärtidning 1989, 41:38-46.
23. Kini R.M. Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon 2003, 42:827-840.
24. Kini R.M. Serine proteases affecting blood coagulation and fibrinolysis from snake venoms. Pathophysiology of Haemostasis and Thrombosis 2005, 34:200-204.
25. Kini R.M. Anticoagulant proteins from snake venoms: structure, function and mechanism. Biochemical Journal 2006, 397:377-387.
26. Kochva E. A quantitative study of venom secretion by Vipera palaestinae. American Journal of Tropical Medicine and Hygiene 1960, 9:381-390.
27. Kochva E. Venomous snakes of Israel: ecology and snakebite. Public Health Reviews 1998, 26:209-232.
28. Kordis D., Bdolah A., Gubensek F. Positive Darwinian selection in Vipera palaestinae phospholipase A2 genes is unexpectedly limited to the third exon. Biochemical and Biophysical Research Communications 1998, 251:613-619.
29. Krizaj I., Bdolah A., Gubensek F., Bencina P., Pungercar J. Protein and cDNA structures of an acidic phospholipase A2, the enzymatic part of an unusual, two-component toxin from Vipera palaestinae. Biochemical and Biophysical Research Communications 1996, 227:374-379.
30. Leonardi A., Fox J.W., Trampus-Bakija A., Krizaj I. Ammodytase, a metalloprotease from Vipera ammodytes ammodytes venom, possesses strong fibrinolytic activity. Toxicon 2007, 49:833-842.
31. Li Q.B., Yu Q.S., Huang G.W., Tokeshi Y., Nakamura M., Kinjoh K., Kosugi T. Hemostatic disturbances observed in patients with snakebite in south China. Toxicon 2000, 38:1355-1366.
32. Li Q.B., Huang G.W., Kinjoh K., Nakamura M., Kosugi T. Hematological studies on DIC-like findings observed in patients with snakebite in south China. Toxicon 2001, 39:943-948.
33. McKay D.G., Moroz C., De Vries A., Csavossy I., Cruse V. The action of hemorrhagin and phospholipase derived from Vipera palestinae venom on the microcirculation. Laboratory Investigation; A Journal of Technical Methods and Pathology 1970, 22:387-399.
34. Mendelssohn H. On the biology of the venomous snakes of Israel. Dapim Refuiim 1962, 21:577-592.
35. Mendelssohn H. On the biology of the venomous snakes of Israel. II. Israel Journal of Zoology 1965, 14:185-212.
36. Moroz C., de Vries A., Sela M. Isolation and characterisation of a neurotoxin from Vipera palestinae venom. Biochimica et Biophysica Acta 1966, 124:136-146.
37. Nakar O., Ovadia M., Kochva E. Isolation and characterisation of a proteolytic factor from the venom of Vipera palaestinae. Toxicon 1986, 24:293-304.
38. Nelson O.L. Use of the D-dimer assay for diagnosing thromboembolic disease in the dog. Journal of the American Animal Hospital Association 2005, 41:145-149.
39. Ovadia M. Isolation and characterisation of three hemorrhagic factors from the venom of Vipera palaestinae. Toxicon 1978, 16:479-487.
40. Ovadia M. Purification and characterisation of an antihemorrhagic factor from the serum of the snake Vipera palaestinae. Toxicon 1978, 16:661-672.
41. Paret G., Ben-Abraham R., Ezra D., Shrem D., Eshel G., Vardi A., Winkler E., Barzilay Z. Vipera palaestinae snake envenomations: experience in children. Human and Experimental Toxicology 1997, 16:683-687.
42. Parkin J.D., Ibrahim K., Dauer R.J., Braitberg G. Prothrombin activation in eastern tiger snake bite. Pathology 2002, 34:162-166.
43. Rucavado A., Soto M., Escalante T., Loria G.D., Arni R., Gutierrez J.M. Thrombocytopenia and platelet hypoaggregation induced by Bothrops asper snake venom. Toxins involved and their contribution to metalloproteinase-induced pulmonary hemorrhage. Thrombosis and Haemostasis 2005, 94:123-131.
44. Samel M., Siigur J. Medium molecular weight factor X activating enzyme from Vipera berus berus venom. Toxicon 1995, 33:41-52.
45. Samel M., Vija H., Subbi J., Siigur J. Metalloproteinase with factor X activating and fibrinogenolytic activities from Vipera berus berus venom. Comparative Biochemistry and Physiology B; Biochemistry and Molecular Biology 2003, 135:575-582.
46. Samel M., Vija H., Ronnholm G., Siigur J., Kalkkinen N., Siigur E. Isolation and characterisation of an apoptotic and platelet aggregation inhibiting l-amino acid oxidase from Vipera berus berus (common viper) venom. Biochimica et Biophysica Acta 2006, 1764:707-714.
47. Segev G., Shipov A., Klement E., Harrus S., Kass P., Aroch I. Vipera palaestinae envenomation in 327 dogs: a retrospective cohort study and analysis of risk factors for mortality. Toxicon 2004, 43:691-699.
48. Shaham N., Bdolah A. l-amino acid oxidase from Vipera palaestinae venom: purification and assay. Comparative Biochemistry and Physiology B 1973, 46:691-698.
49. Shemesh I.Y., Kristal C., Langerman L., Bourvin A. Preliminary evaluation of Vipera palaestinae snake bite treatment in accordance to the severity of the clinical syndrome. Toxicon 1998, 36:867-873.
50. Shiloah J., Klibansky C., de Vries A., Berger A. Phospholipase B activity of a purified phospholipase A from Vipera palaestinae venom. Journal of Lipid Research 1973, 14:267-278.
51. Siigur E., Tonismagi K., Trummal K., Samel M., Vija H., Subbi J., Siigur J. Factor X activator from Vipera lebetina snake venom, molecular characterisation and substrate specificity. Biochimica et Biophysica Acta 2001, 1568:90-98.
52. Siigur J., Aaspollu A., Tonismagi K., Trummal K., Samel M., Vija H., Subbi J., Siigur E. Proteases from Vipera lebetina venom affecting coagulation and fibrinolysis. Haemostasis 2001, 31:123-132.
53. Simon T., Bdolah A., Kochva E. The two-component toxin of Vipera palaestinae: contribution of phospholipase A to its activity. Toxicon 1980, 18:249-259.
54. Sotckham S.L., Scott M.A. Basic hematologic assays. Fundamentals of Veterinary Clinical Pathology 2002, 31-48. Iowa State Press, Iowa. S.L. Stockham, M.A. Scott (Eds.).
55. Stefansson S., Kini R.M., Evans H.J. The inhibition of clotting complexes of the extrinsic coagulation cascade by the phospholipase A2 isoenzymes from Naja nigricollis venom. Thrombosis Research 1989, 55:481-491.
56. Stefansson S., Kini R.M., Evans H.J. The basic phospholipase A2 from Naja nigricollis venom inhibits the prothrombinase complex by a novel nonenzymatic mechanism. Biochemistry 1990, 29:7742-7746.
57. Stokol T. Plasma D-dimer for the diagnosis of thromboembolic disorders in dogs. Veterinary Clinics of North America Small Animal Practice 2003, 33:1419-1435.
58. Tan P.T., Khan A.M., Brusic V. Bioinformatics for venom and toxin sciences. Briefings in Bioinformatics 2003, 4:53-62.
59. Tans G., Rosing J. Snake venom activators of factor X: an overview. Haemostasis 2001, 31:225-233.
60. Tonismagi K., Samel M., Trummal K., Ronnholm G., Siigur J., Kalkkinen N., Siigur E. l-amino acid oxidase from Vipera lebetina venom: isolation, characterisation, effects on platelets and bacteria. Toxicon 2006, 48:227-237.
61. Vilar P., Couto C.G., Westendorf N., Iazbik C., Charske J., Marin L. Thromboelastographic tracings in retired racing greyhounds and in non-greyhound dogs. Journal of Veterinary Internal Medicine 2008, 22:374-379.
62. Wada H., Gabazza E.C., Asakura H., Koike K., Okamoto K., Maruyama I., Shiku H., Nobori T. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis and of the Japanese Ministry of Health and Welfare for overt DIC. American Journal of Hematology 2003, 74:17-22.
63. Yamada D., Sekiya F., Morita T. Prothrombin and factor X activator activities in the venoms of Viperidae snakes. Toxicon 1997, 35:1581-1589.
64. Yukelson L.Y., Tans G., Thomassen M.C., Hemker H.C., Rosing J. Procoagulant activities in venoms from central Asian snakes. Toxicon 1991, 29:491-502.